CLASS II ONGOING Drug recall · Reported 3 Jun 2020 · FDA Enforcement Report
LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch recalled
Wuhan Bingbing Pharmaceutical is recalling LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, distributed nationwide in the US. The recall was initiated on 19 May 2020 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1277-2020
- FDA event ID
- 85726
- Recalling firm
- Wuhan Bingbing Pharmaceutical, Wuhan, N/A
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 19 May 2020
- FDA classified
- 28 May 2020
- Reported
- 3 Jun 2020
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Pain Medication
Timeline
| 19 May 2020 | Recall initiated by company | |
| 28 May 2020 | Classified by FDA | +9 days |
| 3 Jun 2020 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.
Product as listed by the FDA
LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.
Where it was distributed
Nationwide in the USA
Questions about this recall
Why was it recalled?
CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.
Which lots are affected?
Batch #: 1180103, Exp 2021.01.02; 180104, Exp 2021.01.03; 80105, Exp 2021.01.04; 180106, Exp 2021.01.05; 80107, Exp 2021.01.06.
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
3 other products · FDA event 85726This product is part of a recall event; the main page for the event is LidoPro (lidocaine 4%, menthol recalled by Wuhan Bingbing Pharmaceutical.
More recalls from Wuhan Bingbing Pharmaceutical
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Maximum Strength Lidocaine Cold & Hot Patch (lidocaine recalled | Wuhan Bingbing Pharmaceutical | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Mencaine (lidocaine 4.5%, menthol 5%) Patch, 1 patch recalled | Wuhan Bingbing Pharmaceutical | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | LidoPro (lidocaine 4%, menthol recalled by Wuhan Bingbing Pharmaceutical | Wuhan Bingbing Pharmaceutical | Manufacturing (CGMP) Deviations | Nationwide |